Atypical Fractures Rise With Bisphosphonate Use


From the Annual Meeting of the American Society For Bone And Mineral Research

Dr. Ebeling said that he has served as a speaker for Merck, Eli Lilly, Novartis, and Sanofi-Aventis; that he has been on advisory boards for Merck, Amgen, and Novartis; has received educational grants from Amgen, Eli Lilly, and Sanofi-Aventis; and has received research grants from Merck, Novartis, and Amgen.

Next Article: